Status:
COMPLETED
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Diabetes Mellitus Type 2
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
This study will assess the efficacy, safety and tolerability of increasing doses of GK Activator (2) in patients with type 2 diabetes whose condition has not been optimally controlled with one previou...
Eligibility Criteria
Inclusion
- adult patients, 18-75 years of age;
- type 2 diabetes mellitus treated with one oral antihyperglycemic agent for \>=3 months prior to screening.
Exclusion
- type 1 diabetes mellitus;
- treatment with insulin, PPAR agonists or systemic corticosteroids during the 3 months prior to screening;
- women who are pregnant, breast-feeding or not using adequate contraceptive methods.
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
127 Patients enrolled
Trial Details
Trial ID
NCT00366379
Start Date
July 1 2006
End Date
June 1 2007
Last Update
November 2 2016
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
Chandler, Arizona, United States, 85225
2
Oviedo, Florida, United States, 32765
3
Nampa, Idaho, United States, 83687
4
Evansville, Indiana, United States, 47714